[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CL2008000701A1 - Composicion farmaceutica que comprende a eritropoyetina; y su uso para proteger organos para transplante. - Google Patents

Composicion farmaceutica que comprende a eritropoyetina; y su uso para proteger organos para transplante.

Info

Publication number
CL2008000701A1
CL2008000701A1 CL200800701A CL2008000701A CL2008000701A1 CL 2008000701 A1 CL2008000701 A1 CL 2008000701A1 CL 200800701 A CL200800701 A CL 200800701A CL 2008000701 A CL2008000701 A CL 2008000701A CL 2008000701 A1 CL2008000701 A1 CL 2008000701A1
Authority
CL
Chile
Prior art keywords
erythropoyetine
transplant
pharmaceutical composition
protect organs
organs
Prior art date
Application number
CL200800701A
Other languages
English (en)
Inventor
Suzuki Hideki Saito Hiroshi
Original Assignee
Nat University Corp Obihiro Un
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat University Corp Obihiro Un filed Critical Nat University Corp Obihiro Un
Publication of CL2008000701A1 publication Critical patent/CL2008000701A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL200800701A 2007-03-09 2008-03-07 Composicion farmaceutica que comprende a eritropoyetina; y su uso para proteger organos para transplante. CL2008000701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007059632 2007-03-09

Publications (1)

Publication Number Publication Date
CL2008000701A1 true CL2008000701A1 (es) 2008-09-12

Family

ID=39759442

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800701A CL2008000701A1 (es) 2007-03-09 2008-03-07 Composicion farmaceutica que comprende a eritropoyetina; y su uso para proteger organos para transplante.

Country Status (10)

Country Link
US (1) US20100137191A1 (es)
EP (1) EP2143439A4 (es)
JP (1) JP5763882B2 (es)
CN (1) CN101631561A (es)
AR (1) AR065613A1 (es)
CA (1) CA2680236A1 (es)
CL (1) CL2008000701A1 (es)
PE (1) PE20081879A1 (es)
TW (1) TW200904825A (es)
WO (1) WO2008111503A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2737026C (en) 2008-09-26 2019-12-24 Ambrx, Inc. Modified animal erythropoietin polypeptides and their uses
NL2010225C2 (en) * 2013-02-01 2014-08-04 Conradus Ghosal Gho Composition and method for preserving, transporting and storing living biological materials.
CN116492448A (zh) * 2023-04-12 2023-07-28 深圳赛保尔生物药业有限公司 负载peg-epo及间充质干细胞的组合物、药物及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US5166322A (en) 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
KR100263845B1 (ko) 1989-10-13 2000-08-16 스튜어트 엘.왓트 에리트로포이에틴 동형체와 그의 제조방법 및 그를 포함하는제약학적 조성물
IL192290A0 (en) 1993-08-17 2008-12-29 Kirin Amgen Inc Erythropoietin analogs
TW518219B (en) 1996-04-26 2003-01-21 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
JP2003225084A (ja) * 2000-12-28 2003-08-12 Japan Science & Technology Corp 凍結細胞保存剤
US7767643B2 (en) * 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
PA8536201A1 (es) * 2000-12-29 2002-08-29 Kenneth S Warren Inst Inc Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
US6531121B2 (en) * 2000-12-29 2003-03-11 The Kenneth S. Warren Institute, Inc. Protection and enhancement of erythropoietin-responsive cells, tissues and organs
ATE542904T1 (de) 2001-10-29 2012-02-15 Crucell Holland Bv Verfahren und mittel zur herstellung von proteinen mit vorbestimmten posttranslationalen modifikationen
US7468242B2 (en) * 2001-11-05 2008-12-23 Medgenics, Inc. Dermal micro organs, methods and apparatuses for producing and using the same
DE10234192B4 (de) * 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
JPWO2004022545A1 (ja) 2002-09-06 2005-12-22 三菱ウェルファーマ株式会社 移植臓器保護剤
US7459152B2 (en) * 2003-04-23 2008-12-02 Rush University Medical Center Erythropoietin administration to improve graft survival
KR101134435B1 (ko) * 2003-05-01 2012-04-09 메드제닉스 인코포레이티드 진피 미세 기관, 그를 생산 및 이용하기 위한 방법 및 장치
RU2392314C2 (ru) * 2003-12-30 2010-06-20 Аугустинус БАДЕР Способ регенерации ткани
JP2005350363A (ja) 2004-06-08 2005-12-22 Kyorin Pharmaceut Co Ltd ヘムオキシゲナーゼの誘導または誘導促進剤としての４−トリフルオロメチルピリミジン誘導体
JP2005350364A (ja) 2004-06-08 2005-12-22 Kyorin Pharmaceut Co Ltd ヘムオキシゲナーゼの誘導または誘導促進剤としてのプロリン誘導体
JP5025470B2 (ja) * 2004-07-07 2012-09-12 ハー・ルンドベック・アクチエゼルスカベット 新規のカルバミル化ｅｐｏおよびその製造方法

Also Published As

Publication number Publication date
TW200904825A (en) 2009-02-01
WO2008111503A1 (ja) 2008-09-18
EP2143439A4 (en) 2011-06-29
JP5763882B2 (ja) 2015-08-12
CA2680236A1 (en) 2008-09-18
JPWO2008111503A1 (ja) 2010-06-24
EP2143439A1 (en) 2010-01-13
US20100137191A1 (en) 2010-06-03
AR065613A1 (es) 2009-06-17
CN101631561A (zh) 2010-01-20
PE20081879A1 (es) 2009-01-10

Similar Documents

Publication Publication Date Title
CL2007003470A1 (es) Compuestos derivados de urea; composicion farmaceutica que comprende a dichos compuestos; y su uso como antibacterianos.
LTC2140867I2 (lt) Farmacinė kompozicija
CL2008000094A1 (es) Compuestos derivados de pteridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para aumentar la vasodilatacion.
CL2008002319A1 (es) Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2007002446A1 (es) Compuestos derivados de morfolino pirimidina; composicion farmaceutica; y su uso para preparar un medicamento para producir un efecto antiproliferante.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
CL2008002041A1 (es) Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad.
BRPI0815170A2 (pt) Composição farmacêutica que compreende um inibidor de sglt 2
BRPI0813892A2 (pt) composições que compreendem antígenos pneumococcal
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0815190A2 (pt) Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
CL2007003232A1 (es) Compuestos derivados de 5-hidroximetil oxazolidin-2-ona; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar y prevenir infecciones bacterianas.
CL2013000801A1 (es) Composicion farmaceutica que comprende un inhibidor de rankl y una hormona o un derivado de la misma, y uso del inhibidor rankl para preparar dicha composicion
CL2007002021A1 (es) Compuestos derivados de oxoisoindol; composicion farmaceutica que los comprende; y su uso para tratar arritmias.
CL2008000794A1 (es) Compuestos derivados de biarilo y heteroarilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno de hierro.
CL2008001323A1 (es) Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2008000784A1 (es) Compuestos amino-5-[-4-(diflourometoxi) fenil sustituido]-5-fenilmidazolona, inhibidores de b-secretasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar alzheimer, deterioro cognitivo, sindrome de down, disminucion co
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
ES2465478T8 (es) Composiciones farmacéuticas que comprenden brivaracetam
BRPI0810399A2 (pt) Composto, composição farmacêutica que o contém e uso do mesmo
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0907892A2 (pt) Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo